Hyloris Buys Out Maxigesic IV Royalty Rights From Alter Pharma
As Both Companies Sign A €5.75m Renegotiated License Agreement
• By Akriti Seth
Hyloris foregoes all past commitments and future royalty obligations to Alter for Maxigesic IV • Source: Alamy 
